In addition, previous studies revealed that high expression of LIAS and LIPT1 were favorable for the prognosis of clear cell renal cell carcinoma (36), and LIPT1 could also be considered as an indicator of favorable prognosis in melanoma (37). This evidence concerns the gene LIAS and melanoma.